Stockscreener 앱 받기
424.23
0.29%
1.24
시간 외 거래:
423.48
-0.75
-0.18%
전일 마감가:
$422.99
열려 있는:
$425.7
하루 거래량:
376.41K
Relative Volume:
1.00
시가총액:
$9.42B
수익:
-
순이익/손실:
$-518.67M
주가수익비율:
-16.89
EPS:
-25.12
순현금흐름:
$-438.32M
1주 성능:
-3.57%
1개월 성능:
-0.15%
6개월 성능:
+27.08%
1년 성능:
+98.33%
1일 변동 폭
$419.41
$428.25
1주일 범위
$419.41
$452.00
52주 변동 폭
$200.63
$457.16
Madrigal Pharmaceuticals Inc Stock (MDGL) Company Profile
명칭
Madrigal Pharmaceuticals Inc
전화
404-380-9263
주소
200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA
MDGL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MDGL
Madrigal Pharmaceuticals Inc
|
424.23 | 9.43B | 0 | -518.67M | -438.32M | -25.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.74 | 97.91B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.90 | 58.88B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.40 | 58.93B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
711.62 | 43.52B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
326.06 | 36.11B | 3.81B | -644.79M | -669.77M | -6.24 |
Madrigal Pharmaceuticals Inc Stock (MDGL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 재개 | H.C. Wainwright | Buy |
| 2025-02-28 | 업그레이드 | B. Riley Securities | Neutral → Buy |
| 2025-02-27 | 재확인 | H.C. Wainwright | Buy |
| 2024-06-28 | 개시 | Cantor Fitzgerald | Neutral |
| 2024-06-11 | 개시 | Wolfe Research | Outperform |
| 2024-04-22 | 개시 | BofA Securities | Underperform |
| 2024-03-15 | 업그레이드 | B. Riley Securities | Sell → Neutral |
| 2024-03-06 | 개시 | Citigroup | Buy |
| 2024-02-26 | 다운그레이드 | B. Riley Securities | Neutral → Sell |
| 2022-12-20 | 재확인 | Oppenheimer | Outperform |
| 2022-12-19 | 재확인 | H.C. Wainwright | Buy |
| 2022-12-19 | 재확인 | Piper Sandler | Overweight |
| 2022-12-19 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2022-07-08 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2021-10-07 | 개시 | Jefferies | Buy |
| 2021-08-06 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2021-05-20 | 재개 | Goldman | Buy |
| 2020-11-24 | 재개 | Evercore ISI | Outperform |
| 2020-11-06 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-31 | 개시 | Piper Sandler | Overweight |
| 2020-06-05 | 개시 | BMO Capital Markets | Market Perform |
| 2020-05-05 | 개시 | Chardan Capital Markets | Buy |
| 2020-01-30 | 개시 | Canaccord Genuity | Buy |
| 2020-01-09 | 업그레이드 | UBS | Neutral → Buy |
| 2019-11-07 | 재확인 | H.C. Wainwright | Buy |
| 2019-06-25 | 개시 | Stifel | Hold |
| 2019-06-10 | 업그레이드 | B. Riley FBR | Neutral → Buy |
| 2019-02-28 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-22 | 개시 | SVB Leerink | Outperform |
| 2019-01-23 | 개시 | UBS | Neutral |
| 2018-12-14 | 개시 | Wolfe Research | Outperform |
| 2018-12-12 | 개시 | B. Riley FBR | Neutral |
| 2018-11-19 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
| 2018-11-16 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-09-04 | 개시 | Citigroup | Buy |
| 2018-08-06 | 다운그레이드 | Goldman | Buy → Neutral |
| 2018-06-28 | 개시 | Raymond James | Mkt Perform |
모두보기
Madrigal Pharmaceuticals Inc 주식(MDGL)의 최신 뉴스
What drives Madrigal Pharmaceuticals Inc YDO1 stock priceHigh Frequency Trading Trends & Small Budget Capital Investment - Early Times
What drives Madrigal Pharmaceuticals Inc stock priceSupport and Resistance Levels & Rapid Capital Trading - Early Times
Madrigal Pharmaceuticals Announces Positive Quality of Life Outcomes for Rezdiffra in NASH Treatment - MSN
What analysts say about Madrigal Pharmaceuticals Inc stockSupport Zone Identification & Unlock Long-Term Capital Growth Ideas - Early Times
Madrigal Pharmaceuticals Inc Stock Analysis and ForecastAutomated Trading Signals & Low Entry Capital Stocks - Early Times
Madrigal Pharmaceuticals (MDGL) Gets a Buy from UBS - The Globe and Mail
Strs Ohio Acquires Shares of 1,900 Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal Pharmaceuticals Grants Equity Awards to 76 New Employees - MSN
Analyst Downgrade: Is Madrigal Pharmaceuticals Inc. affected by consumer sentimentSell Signal & Consistent Profit Trading Strategies - خودرو بانک
Fund Flows: Is Diana Shipping Inc vulnerable to short sellers2025 Major Catalysts & Technical Buy Zone Confirmations - khodrobank.com
Treasury Yields: Will Madrigal Pharmaceuticals Inc. outperform during market ralliesQuarterly Portfolio Summary & Growth Focused Entry Point Reports - خودرو بانک
Bond Watch: Can Madrigal Pharmaceuticals Inc weather a recessionOptions Play & Safe Capital Growth Plans - خودرو بانک
Leadership Changes at Madrigal Pharmaceuticals Mark New Phase of Growth - MSN
How to read the order book for Madrigal Pharmaceuticals Inc.Profit Target & AI Enhanced Trading Alerts - newser.com
Value Recap: Can Madrigal Pharmaceuticals Inc stock double in the next year2025 Institutional Moves & Real-Time Market Sentiment Alerts - خودرو بانک
Smart Money: What is Madrigal Pharmaceuticals Incs TAM Total Addressable MarketJuly 2025 Closing Moves & Daily Oversold Stock Bounce Ideas - khodrobank.com
Growth Value: Does ENERR have pricing powerJuly 2025 Final Week & Weekly Watchlist for Consistent Profits - khodrobank.com
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Madrigal Pharmaceuticals gains amid takeover speculation - MSN
Madrigal Pharmaceuticals Reports Strong 2024 Growth Fueled by Rezdiffra Launch - MSN
Madrigal Pharmaceuticals announces grants of inducement awards - MarketScreener
76 New Hires: Madrigal Pharmaceuticals Awards 31.8K RSUs and Stock Options in MASH Drug Expansion - Stock Titan
Investment Report: What are Madrigal Pharmaceuticals Incs recent SEC filings showingBull Run & Daily Profit Focused Screening - خودرو بانک
Intech Investment Management LLC Purchases 1,696 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - MarketBeat
EP Wealth Advisors LLC Makes New Investment in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Rhumbline Advisers Acquires 1,924 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Market Overview: Can Madrigal Pharmaceuticals Inc weather a recession2025 Volume Leaders & Safe Capital Growth Stock Tips - khodrobank.com
Madrigal (MDGL) Secures $500M to Fuel MASH Pipeline Expansion - MSN
Growth Value: Will Madrigal Pharmaceuticals Inc outperform during market ralliesJuly 2025 Big Picture & Fast Gaining Stock Strategy Reports - خودرو بانک
Earnings Recap: Is Madrigal Pharmaceuticals Inc benefiting from innovation trendsStop Loss & Fast Entry and Exit Trade Plans - خودرو بانک
Market Review: What are Madrigal Pharmaceuticals Incs earnings expectationsEarnings Growth Summary & Weekly High Conviction Trade Ideas - خودرو بانک
Pullback Watch: Is Madrigal Pharmaceuticals Inc stock good for income investors2025 Technical Patterns & Daily Growth Stock Tips - خودرو بانک
Madrigal stock jumps 13% after Rezdiffra Q3 sales beat estimates - MSN
Downgrade Watch: What is the next catalyst for ATEXWeekly Gains Summary & Technical Confirmation Alerts - خودرو بانک
Aug PostEarnings: Is Madrigal Pharmaceuticals Inc stock forming a cup and handleLayoff News & Technical Buy Zone Confirmation - خودرو بانک
Short Squeeze: How is Capital City Bank Group Inc. managing supply chain issuesPortfolio Risk Report & Daily Stock Momentum Reports - خودرو بانک
Recap Report: Does Madrigal Pharmaceuticals Inc. stock benefit from AI growthJuly 2025 Patterns & Weekly Consistent Profit Watchlists - خودرو بانک
Woodline Partners LP Raises Holdings in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal Pharmaceuticals (NASDAQ:MDGL) CEO Sells $3,243,740.77 in Stock - MarketBeat
Assessing Madrigal Pharmaceuticals (MDGL) Valuation After Rezdiffra’s Strong Q2 Sales and EU Approval - Sahm
Canaccord Genuity Group Forecasts Strong Price Appreciation for Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock - Defense World
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Madrigal Pharmaceuticals stock price target raised by Canaccord on MASH drug outlook - Investing.com Canada
Madrigal Pharmaceuticals (NASDAQ:MDGL) Reaches New 12-Month HighTime to Buy? - MarketBeat
What is HC Wainwright's Estimate for MDGL Q3 Earnings? - MarketBeat
Canaccord Genuity Boosts Madrigal Pharmaceuticals (MDGL) Price T - GuruFocus
Madrigal Pharmaceuticals Inc (MDGL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.41%
0.81%
자본화:
|
볼륨(24시간):